Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Asthma Therapy
Research add new data to asthma therapy body of knowledge
November 18th, 2005
New findings from Scotland, the the Netherlands and Italy describe advances in asthma therapy. Study 1: Inhaler choice does not significantly affect budesonide efficacy in asthma patients. "Bronchial hyperresponsiveness to adenosine monophosphate, an indirect measure of airway inflammation, is a sensitive marker of inhaled corticosteroid efficacy," scientists in Scotland noted. In a "double-masked, dose-response crossover study," they compared the "relative therapeutic efficacy of budesonide delivered via Clickhaler and Turbuhaler dry powder inhalers in patients with mild-to-moderate persistent asthma." "Twenty-seven patients...
Source: Drug Week (2005-11-18)
|
